HC Wainwright restated their buy rating on shares of Korro Bio (NASDAQ:KRRO – Free Report) in a research report report published on Tuesday morning, MarketBeat.com reports. HC Wainwright currently has a $15.00 price objective on the stock. A number of other equities analysts have also issued reports on KRRO. Wall Street Zen raised Korro Bio […]
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.